A randomized, open-label, assessor blind, parallel, active-controlled, multicentric, bridging clinical trial to evaluate the immunogenicity and safety of three dose THRABIS vaccine (Recombinant Rabies G Protein Vaccine), administered as a simulated post-exposure immunization in healthy children - THRABIS vaccine